(Q37137669)

18 August 2017

1 reference

title

Lymphangioleiomyomatosis and tuberous sclerosis complex (English)

1 reference

18 August 2017

1 reference

Dimitrios Chorianopoulos

series ordinal

1

1 reference

18 August 2017

Grigoris Stratakos

series ordinal

2

1 reference

18 August 2017

publication date

12 April 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

186

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

197-207

1 reference

https://scigraph.springernature.com/pub.10.1007/s00408-008-9087-5

18 August 2017

exact match

0 references

cites work

The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Emerging clinical picture of lymphangioleiomyomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Clinical experience of lymphangioleiomyomatosis in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous oestrogen used for infertility treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Extrapulmonary lymphangioleiomyomatosis and lymphangiomatous cysts in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Lymphangioleiomyomatosis: a clinical update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Lymphangioleiomyomatosis and tuberous sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Prevalence and Clinical Characteristics of Lymphangioleiomyomatosis (LAM) in Patients with Tuberous Sclerosis Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

The tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Chromosome 16 Loss of Heterozygosity in Tuberous Sclerosis and Sporadic Lymphangiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Pulmonary lymphangioleiomyomatosis (LAM): progress and current challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: Role for tumor suppressor TSC2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Tissue inhibitor of metalloproteinase-3 downregulation in lymphangioleiomyomatosis: potential consequence of abnormal serum response factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Pleural disease in lymphangioleiomyomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Reversible Airflow Obstruction, Proliferation of Abnormal Smooth Muscle Cells, and Impairment of Gas Exchange as Predictors of Outcome in Lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Diffuse cystic lung diseases: correlation between radiologic and functional status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Effect of encouragement on walking test performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Transbronchial Biopsy in Lymphangiomyomatosis of the Lung HMB45 for Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Pulmonary lymphangioleiomyomatosis (LAM): examining oral contraceptive pills and the onset of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Bone mineral density in lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Regulation of PDGF production and ERK activation by estrogen is associated withTSC2gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Treatment of lymphangioleiomyomatosis. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Successful treatment of pulmonary lymphangioleiomyomatosis with progestins: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Depressive symptoms in users and non-users of depot medroxyprogesterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Chylothorax in lymphangioleiomyomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Low initial KCO predicts rapid FEV1 decline in pulmonary lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Survival and disease progression in UK patients with lymphangioleiomyomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Sirolimus--challenging current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Mycophenolate mofetil and sirolimus combination in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Doxycycline alters vascular smooth muscle cell adhesion, migration, and reorganization of fibrillar collagen matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

TSC1–TSC2: a complex tale of PKB-mediated S6K regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-008-9087-5

Lung transplantation for lymphangioleiomyomatosis

21 January 2018

1 reference

12 December 2020

Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study

1 reference

12 December 2020

The LAM cell: what is it, where does it come from, and why does it grow?

1 reference

12 December 2020

Lymphangioleiomyomatosis: recurrence after single lung transplantation

1 reference

12 December 2020

Lymphangioleiomyomatosis: a complex tale of serum response factor-mediated tissue inhibitor of metalloproteinase-3 regulation

1 reference

12 December 2020

Pulmonary cysts consistent with lymphangioleiomyomatosis are common in women with tuberous sclerosis: genetic and radiographic analysis

1 reference

12 December 2020

Sirolimus treatment for pulmonary lymphangioleiomyomatosis

1 reference

12 December 2020

An integrated clinical approach to diffuse cystic lung diseases

1 reference

12 December 2020

Lymphangioleiomyomatosis

1 reference

12 December 2020

Pregnancy complicated with pulmonary lymphangioleiomyomatosis: case report.

1 reference

12 December 2020

Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation

1 reference

12 December 2020

Clinical and molecular insights into lymphangioleiomyomatosis.

1 reference

12 December 2020

Estrogen and Progesterone Receptors in Lymphangioleiomyomatosis, Epithelioid Hemangioendothelioma, and Sclerosing Hemangioma of the Lung

1 reference

12 December 2020

[Treatment of pulmonary lymphangioleiomyomatosis using a GnRH agonist]

1 reference

12 December 2020

Lymphangioleiomyomatosis

1 reference

12 December 2020

A report of two long-surviving cases of pulmonary lymphangioleiomyomatosis and the response to progesterone therapy

1 reference

12 December 2020

Pulmonary lymphangioleiomyomatosis in a postmenopausal woman: case report with review of literature

1 reference

12 December 2020

Lymphangioleiomyomatosis

1 reference

12 December 2020

Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests

1 reference

12 December 2020

Lymphangioleiomyomatosis: a review

1 reference

12 December 2020

Renal angiomyolipoma: a clinicopathologic, immunohistochemical, and follow-up study of 46 cases

1 reference

12 December 2020

Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis

1 reference

12 December 2020

[Role of embolization in renal angiomyolipomas]

1 reference

12 December 2020

10.1007/S00408-008-9087-5

Identifiers

DOI

1 reference

18 August 2017

1 reference